Comparison 9. Lidocaine vs pirmenol.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
9.1 Adverse event | 1 | 19 | Risk Ratio (M‐H, Random, 95% CI) | 1.11 [0.47, 2.60] |
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
9.1 Adverse event | 1 | 19 | Risk Ratio (M‐H, Random, 95% CI) | 1.11 [0.47, 2.60] |